ASTRO 2024: SABR for primary kidney cancer – Is it ready for ‘primetime’?
In this presentation at the 2024 American Society for Radiation [...]
In this presentation at the 2024 American Society for Radiation [...]
Stereotactic ablative body radiotherapy (SABR) uses high doses of radiation [...]
The incidence of renal cell carcinoma (RCC) has increased worldwide [...]
Stereotactic ablative radiotherapy (SABR) for treating the primary kidney cancer [...]
A recent study looked at the outcomes of patients with [...]
Stereotactic ablative body radiotherapy (SABR) uses an intense beam of [...]
Stereotactic ablative radiotherapy (SABR) is mostly used for the treatment [...]
Stereotactic ablative body radiotherapy (SABR) is a procedure that uses [...]
At the European International Kidney Cancer Symposium (EIKCS) in Antwerp, [...]
A new study from the USA shows that highly focused [...]